Cover Image
市場調查報告書

全球生物外科手術市場調查及分析

Global Biosurgery Market Research and Analysis, 2015-2022

出版商 Orion Market Research Pvt Ltd 商品編碼 523701
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
全球生物外科手術市場調查及分析 Global Biosurgery Market Research and Analysis, 2015-2022
出版日期: 2017年06月16日 內容資訊: 英文
簡介

本報告提供全球生物外科手術市場相關調查,彙整市場概要,各終端用戶,各產品,各用途,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 本報告的摘要

第2章 市場概要與趨勢

  • 定義
  • 分析師的見解與目前市場趨勢
  • 法律規章

第3章 市場決策因素

  • 促進要素
  • 阻礙要素
  • 機會

第4章 市場區隔

  • 各產品
    • 血袋
    • 血液採血針
    • 管瓶
    • 採血管
    • 採血針及注射器
    • 其他
  • 各用途
    • 感染疾病診斷
    • 非感染疾病診斷
  • 各終端用戶
    • 醫院
    • 診斷中心及實驗室
    • 血庫
    • 其他

第5章 競爭環境

  • 主要策略
  • 主要企業分析

第6章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: OMR2017131

Market Insights

The market is expected to grow at a CAGR of 9.5% from 2017-2022, owing to increasing number of surgeries and rising demand for technologically upgraded surgical processes. Rising cases of sports related injuries and increasing geriatric population are also factors responsible for growth of biosurgery market. Increasing number of surgeries and rising adoption of minimally invasive surgeries across the globe are driving the market. Biosurgery enable to enhance physician's efficiency during various critical surgeries of CVD, urology, orthopedic, thoracic and so on. Bio-surgery involves a range of surgical techniques which includes natural or synthetic materials to seal surgical incisions that are biodegradable in nature. Hemostatic agents and sealants provided by the biosurgery market players are used during the surgeries to stop bleeding and seal wounds in surgery. Biosurgeries products such as surgical sealant, soft tissue attachments, bone graft substitutes are increasingly adopted across the globe which also helps in post surgery complications. Other products such as collagen based hemostatic powder, biodegradable guided healing membrane, hemostatic and osteoconductive bone substitute matrix are the products used in the biosurgery market that are widely adopted across the globe.

Moreover, various other biosurgery products available in the market include hemostatic products, sealants, soft tissue repair products, staple line reinforcement products and adhesion prevention products. The natural bio surgery products comprise allografts, cultured epithelial autografts, and xenografts However, high costs of biosurgery and lack of reimbursements act as inhibiting factors for market growth. Various innovations and investments in research and development by key market players are expected to create opportunities for biosurgery products, especially in emerging markets.

Geographical Insights

North America dominates the market during the forecasted period due to the availability of sophisticated healthcare system, rising healthcare spending and rising adoption of technologically upgraded surgeries and devices. Increasing investments in research and development in biosurgery market are also boosting market growth. APAC is estimated to be the fastest growing market owing to increasing healthcare expenditure and increasing awareness of biosurgery. Rising patient pool and increasing medical tourism are also expected to fuel the market growth in this region.

Competitive Insights

The key players in the global biosurgery market profiled in this report include Aroa Biosurgery, Atrium Medical Corporation, B. Braun Melsungen AG, Baxter International Inc., Biom'Up, C.R. Bard, Inc., Covidien Plc., Cryolife, Inc., Ethicon, Hemostasis, Kuros, Biosciences, Osiris Therapeutics, Sanofi Group And Stryker Corporation. R&D, M&A, partnership, collaboration are the key strategies adopted by the market players to stay competitive.

Market segmentation

The market is segmented by product, applications and geography. The market segmentation on the basis of product include Bone Graft Substitutes, Soft Tissue Attachments, Surgical Sealants, haemostatic agents and staple line reinforcement static agents. On the basis of applications, the market is segregated into cardiovascular surgeries, neurological surgeries, urology surgeries, gynecology surgeries, general surgeries, thoracic surgeries, orthopedic surgeries and reconstructive surgeries. The market is segmented on the basis of geography which includes North America, Europe, APAC and RoW. The market is segmented on the basis of products and applications which includes-

Global Biosurgery Market Research and Analysis, By Products,

  • 1.2. Bone Graft Substitutes
    • 1.2.1. Bone Allografts
    • 1.2.2. Demineralized Bone Matrix
    • 1.2.3. Bone Morphogenetic Proteins
    • 1.2.4. Synthetic Bone Grafts
  • 1.3. Soft Tissue Attachments
    • 1.3.1. Synthetic Mesh
    • 1.3.2. Biological Mesh
      • 1.3.2.1. Allografts
      • 1.3.2.2. Xenografts
  • 1.4. Surgical Sealants
    • 1.4.1. Fibrin Sealants
    • 1.4.2. Synthetic Agents
    • 1.4.3. Collagen Based Sealants
    • 1.4.4. Tissue Adhesive Glues
  • 1.5. Hemostatic Agents
  • 1.6. Staple Line Reinforcement Static Agents

Biosurgery Market Research and Analysis, By Applications

  • 2.1. Cardiovascular Surgeries
  • 2.2. Neurological Surgeries
  • 2.3. Urology Surgeries
  • 2.4. Gynaecology Surgeries
  • 2.5. Orthopedic Surgeries
  • 2.6. Thoracic Surgeries
  • 2.7. Reconstructive Surgeries
  • 2.8. General Surgeries

OMR Report covers:

Comprehensive research methodology of Global Biosurgery Market.

This report also includes detailed and extensive market overview with Analyst insights & key market trends.

Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the Global Biosurgery Market.

Insights about market determinants which are stimulating the Global Biosurgery Market.

Detailed and extensive market segments with regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. REPORT SUMMARY

  • 1.1. RESEARCH METHODS AND TOOLS
  • 1.2. MARKET BREAKDOWN
    • 1.2.1. BY SEGMENTS
    • 1.2.2. BY GEOGRAPHY
    • 1.2.3. BY STAKEHOLDERS
    • 1.2.4. EXCEPTIONS

2. MARKET OVERVIEW AND INSIGHTS

  • 2.1. DEFINITION
  • 2.2. GAP ANALYSIS
  • 2.3. HISTORICAL ANALYSIS
  • 2.4. CURRENT MARKET TRENDS
  • 2.5. PIPELINE ANALYSIS
  • 2.6. ANALYST INSIGHT
    • 2.6.1. KEY FINDINGS
    • 2.6.2. RECOMMENDATION
    • 2.6.3. CONCLUSION
  • 2.7. REGULATION
    • 2.7.1. DRUG AND DEVICE REGULATIONS
      • 2.7.1.1. UNITED STATES
      • 2.7.1.2. EUROPEAN UNION
      • 2.7.1.3. CHINA
      • 2.7.1.4. INDIA
      • 2.7.1.5. REST OF THE WORLD

3. MARKET DETERMINANTS

  • 3.1. MOTIVATORS
    • 3.1.1. INCREASING NUMBER OF SURGERIES
    • 3.1.2. INCREASE IN GERIATRIC POPULATION
    • 3.1.3. RISING DEMAND FOR TECHNOLOGICALLY UPGRADED SURGICAL PROCESSES
    • 3.1.4. INCREASING INCIDENCES OF SPORT RELATED INJURIES AND SPINAL CORD PROBLEMS
  • 3.2. RESTRAINT
    • 3.2.1. HIGH COSTS
    • 3.2.2. LIMITED REIMBURSEMENTS
  • 3.3. OPPORTUNITY
    • 3.3.1. INNOVATIONS IN BIOSURGERY
    • 3.3.2. EMERGING MARKETS

4. GLOBAL SURGERY MARKET ANALYSIS

5. MARKET SEGMENTATION

  • 5.1. BY PRODUCTS
    • 5.1.1. ADHESION BARRIERS
    • 5.1.2. BONE GRAFT SUBSTITUTES
      • 5.1.2.1. BONE ALLOGRAFTS
      • 5.1.2.2. DEMINERALIZED BONE MATRIX
      • 5.1.2.3. BONE MORPHOGENETIC PROTEINS
      • 5.1.2.4. SYNTHETIC BONE GRAFTS
    • 5.1.3. SOFT TISSUE ATTACHMENTS
      • 5.1.3.1. SYNTHETIC MESH
      • 5.1.3.2. BIOLOGICAL MESH
        • 5.1.3.2.1. ALLOGRAFTS
        • 5.1.3.2.2. XENOGRAFTS
    • 5.1.4. SURGICAL SEALANTS
      • 5.1.4.1. FIBRIN SEALANTS
      • 5.1.4.2. SYNTHETIC AGENTS
      • 5.1.4.3. COLLAGEN BASED SEALANTS
      • 5.1.4.4. TISSUE ADHESIVE GLUES
    • 5.1.5. HEMOSTATIC AGENTS
    • 5.1.6. STAPLE LINE REINFORCEMENT STATIC AGENTS
  • 5.2. BIOSURGERY BY APPLICATIONS,
    • 5.2.1. CARDIOVASCULAR SURGERIES
    • 5.2.2. NEUROLOGICAL SURGERIES
    • 5.2.3. UROLOGY SURGERIES
    • 5.2.4. GYNAECOLOGY SURGERIES
    • 5.2.5. ORTHOPEDIC SURGERIES
    • 5.2.6. THORACIC SURGERIES
    • 5.2.7. RECONSTRUCTIVE SURGERIES
    • 5.2.8. GENERAL SURGERIES

6. COMPETITIVE LANDSCAPE

  • 6.1. KEY STARTEGY ANALYSIS
  • 6.2. KEY COMPANY ANALYSIS

7. REGIONAL ANALYSIS

  • 7.1. NORTH AMERICAN
    • 7.1.1. UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPEAN
    • 7.2.1. WESTERN EUROPE
    • 7.2.2. ROE
  • 7.3. ASIA PACIFIC
    • 7.3.1. INDIA
    • 7.3.2. CHINA
    • 7.3.3. JAPAN
    • 7.3.4. ROAPAC
  • 7.4. REST OF THE WORLD

8. COMPANY PROFILES

  • 8.1. AROA BIOSURGERY
    • 8.1.1. INTRODUCTION
    • 8.1.2. AROA BIOSURGERY PRODUCT PORTFOLIO
    • 8.1.3. AROA BIOSURGERY RECENT ACTIVITIES
  • 8.2. ATRIUM MEDICAL CORPORATION
    • 8.2.1. INTRODUCTION
    • 8.2.2. ATRIUM MEDICAL CORPORATION PRODUCT PORTFOLIO
    • 8.2.3. ATRIUM MEDICAL CORPORATION RECENT ACTIVITIES
  • 8.3. B. BRAUN MELSUNGEN AG
    • 8.3.1. INTRODUCTION
    • 8.3.2. B. BRAUN MELSUNGEN AG PRODUCT PORTFOLIO
    • 8.3.3. B. BRAUN MELSUNGEN AG RECENT ACTIVITIES
  • 8.4. BAXTER INTERNATIONAL INC.
    • 8.4.1. INTRODUCTION
    • 8.4.2. BAXTER INTERNATIONAL INC. PRODUCT PORTFOLIO
    • 8.4.3. BAXTER INTERNATIONAL INC. RECENT ACTIVITIES
  • 8.5. BIOM'UP
    • 8.5.1. INTRODUCTION
    • 8.5.2. BIOM'UP PRODUCT PORTFOLIO
    • 8.5.3. BIOM'UP RECENT ACTIVITIES
  • 8.6. C.R. BARD, INC.
    • 8.6.1. INTRODUCTION
    • 8.6.2. C.R. BARD, INC. PRODUCT PORTFOLIO
    • 8.6.3. C.R. BARD, INC. RECENT ACTIVITIES
  • 8.7. COVIDIEN PLC.
    • 8.7.1. INTRODUCTION
    • 8.7.2. COVIDIEN PLC. PRODUCT PORTFOLIO
    • 8.7.3. COVIDIEN PLC. RECENT ACTIVITIES
  • 8.8. CRYOLIFE, INC.
    • 8.8.1. INTRODUCTION
    • 8.8.2. CRYOLIFE, INC. PRODUCT PORTFOLIO
    • 8.8.3. CRYOLIFE, INC. RECENT ACTIVITIES
  • 8.9. ETHICON
    • 8.9.1. INTRODUCTION
    • 8.9.2. ETHICON PRODUCT PORTFOLIO
    • 8.9.3. ETHICON RECENT ACTIVITIES
  • 8.10. HEMOSTASIS, LLC
    • 8.10.1. INTRODUCTION
    • 8.10.2. HEMOSTASIS, LLC PRODUCT PORTFOLIO
    • 8.10.3. HEMOSTASIS, LLC RECENT ACTIVITIES
  • 8.11. KUROS BIOSCIENCES
    • 8.11.1. INTRODUCTION
    • 8.11.2. KUROS BIOSCIENCES PRODUCT PORTFOLIO
    • 8.11.3. KUROS BIOSCIENCES RECENT ACTIVITIES
  • 8.12. OSIRIS THERAPEUTICS
    • 8.12.1. INTRODUCTION
    • 8.12.2. OSIRIS THERAPEUTICS PRODUCT PORTFOLIO
    • 8.12.3. OSIRIS THERAPEUTICS RECENT ACTIVITIES
  • 8.13. SANOFI GROUP
    • 8.13.1. INTRODUCTION
    • 8.13.2. SANOFI GROUP PRODUCT PORTFOLIO
    • 8.13.3. SANOFI GROUP RECENT ACTIVITIES
  • 8.14. STRYKER CORPORATION
    • 8.14.1. INTRODUCTION
    • 8.14.2. STRYKER CORPORATION PRODUCT PORTFOLIO
    • 8.14.3. STRYKER CORPORATION RECENT ACTIVITIES

List of Tables

  • TABLE # 1 GLOBAL BIOSURGERY MARKET RESEARCH AND ANALYSIS, BY PRODUCTS, 2015-2021 ($ MILLION)
  • TABLE # 2 GLOBAL ADHESION BARRIERS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 3 GLOBAL BONE GRAFT SUBSTITUTES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 4 GLOBAL BONE ALLOGRAFTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 5 GLOBAL DEMINERALIZED BONE MATRIX MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 6 GLOBAL BONE MORPHOGENETIC PROTEINS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 7 GLOBAL SYNTHETIC BONE GRAFTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 8 GLOBAL SOFT TISSUE ATTACHMENTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 9 GLOBAL SYNTHETIC MESH MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 10 GLOBAL BIOLOGICAL MESH MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 11 GLOBAL ALLOGRAFTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 12 GLOBAL XENOGRAFTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 13 GLOBAL SURGICAL SEALANTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 14 GLOBAL FIBRIN SEALANTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 15 GLOBAL SYNTHETIC AGENTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 16 GLOBAL COLLAGEN BASED SEALANTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 17 GLOBAL TISSUE ADHESIVE GLUES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 18 GLOBAL HEMOSTATIC AGENTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 19 GLOBAL STAPLE LINE REINFORCEMENT STATIC AGENTS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 20 GLOBAL BIOSURGERY MARKET RESEARCH AND ANALYSIS, BY APPLICATIONS, 2015-2021 ($ MILLION)
  • TABLE # 21 GLOBAL CARDIOVASCULAR SURGERIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 22 GLOBAL NEUROLOGICAL SURGERIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 23 GLOBAL UROLOGY SURGERIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 24 GLOBAL GYNAECOLOGY SURGERIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 25 GLOBAL ORTHOPEDIC SURGERIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 26 GLOBAL THORACIC SURGERIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 27 GLOBAL RECONSTRUCTIVE SURGERIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
  • TABLE # 28 GLOBAL GENERAL SURGERIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)

List of Figures

  • FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
  • FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
Back to Top